Chris Degnan
Director of Finance/CFO at GALERA THERAPEUTICS, INC.
Net worth: 2 070 $ as of 2024-04-29
Chris Degnan active positions
Companies | Position | Start | End |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Director of Finance/CFO | 2019-10-20 | - | |
Investor Relations Contact | 2019-10-20 | - | |
Corporate Secretary | 2019-10-20 | - |
Career history of Chris Degnan
Former positions of Chris Degnan
Companies | Position | Start | End |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 2018-02-28 | 2019-10-06 |
Director of Finance/CFO | 2018-02-28 | 2019-10-06 | |
ENDO INTERNATIONAL PLC | Director of Finance/CFO | 2014-10-31 | 2018-02-28 |
ASTRAZENECA PLC | Director of Finance/CFO | 2003-12-31 | 2014-10-31 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director of Finance/CFO | - | - |
Training of Chris Degnan
University of Notre Dame | Undergraduate Degree |
Statistics
International
United States | 5 |
Ireland | 2 |
United Kingdom | 2 |
Operational
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Stock Market
- Insiders
- Chris Degnan
- Experience